Zevra Therapeutics Announces Details for Q4 and Full Year 2025 Financial Results Call
Is Zevra Therapeutics (ZVRA) Pricing Reflect Its Strong DCF Upside Potential? [Yahoo! Finance]
Zevra Therapeutics to Present at the Citizens Life Sciences Conference
Zevra Therapeutics Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
Zevra Therapeutics Presents Positive New Real-World Data on MIPLYFFA® in Patients with Neimann-Pick Disease Type C (NPC) at the 22nd Annual WORLDSymposium™ [Yahoo! Finance]